Alphabet

Corporate

Portfolio

companies

Portfolio companies

Isomorphic Labs

Isomorphic Labs develops artificial intelligence systems to design new therapeutics and accelerate drug discovery.

Recent investments

Other31 March 2025

£459M

Isomorphic Labs secures £458.6m in a funding round led by Thrive Capital to advance its artificial intelligence drug design engine.

AI/ML BioTech

The financing round was led by Thrive Capital with backing from GV and Alphabet.

"We’re excited to bring together a top-tier investor group with deep AI and life sciences expertise as we aim to transform this industry through an interdisciplinary approach."

— Sir Demis Hassabis, Founder and CEO

Isomorphic Labs—London, UK

Thrive Capital + 2 others